jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

June. 22, 2026

June. 22, 2026

jRCT2031260244

A Phase III, Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel-Group Study of M610101 in Patients with Atopic Dermatitis

A Phase III Study of M610101 in Patients with Atopic Dermatitis

Nishiura Tomoyuki

Maruho Co.,Ltd. Kyoto R&D Center

93 Chudoji Awatacho, Shimogyo-ku, Kyoto

+81-75-325-3279

ctinfo@mii.maruho.co.jp

- Clinical Trials Information

Maruho Co.,Ltd. Kyoto R&D Center

93 Chudoji Awatacho, Shimogyo-ku, Kyoto

+81-75-325-3279

ctinfo@mii.maruho.co.jp

Recruiting

June. 22, 2026

150

Interventional

randomized controlled trial

double blind

placebo control

parallel assignment

treatment purpose

(1)Patients with atopic dermatitis aged 2 years to 12 years
(2)Patients with an IGA score of 2 or 3 for atopic dermatitis
(3)Patients with 3% to 20% BSA involvement of atopic dermatitis

(1)Patients complicated with diseases considered inappropriate for participation in clinical trials such as serious cardiac / hepatic / renal / pulmonary / hematologic disease
(2)Patients with skin diseases other than atopic dermatitis that affect the evaluation of atopic dermatitis or the safety of the subject

2age old over
12age old not

Both

Atopic dermatitis

Apply 2 times a day.

Proportion of participants achieving an IGA score of 0 or 1 with at least a 2-point improvement from baseline at week 8

Maruho Co.,Ltd.
Medical corporation Shintoukai Yokohamaminoru Clinic IRB
1-13-8, Bessho Minami-ku Yokohama-shi, Kanagawa

+81-42-648-5551

yminoru-irb@eps.co.jp
Not approval

No

none